The entire project's knowledge base is built upon **three**
**foundational** **data** **pillars**. Below is the detailed, structured
strategy that outlines exactly what kind of data we will acquire from
which authority, and the best technical method for ingestion.

**Viro-AI** **Data** **Sourcing** **and** **Acquisition** **Strategy**

The complexity of the 40GB dataset requires a programmatic approach for
bulk acquisition, moving away from manual downloads, to eficiently feed
the Predictive Engine, Antidote Generation Module, and Simulation &
Visualization Module.1

**Pillar** **1:** **Genomic** **Data** **(Sequences** **and**
**Mutations)**

This data is the fundamental blueprint for the virus. It is critical for
the **Predictive** **Engine** to analyze genetic sequences and forecast
future mutations, aiming for \>69% accuracy.1

||
||
||
||
||

||
||
||
||

**Pillar** **2:** **Structural** **Data** **(3D** **Protein**
**Structures)**

This data provides the atomic-level geometry necessary for the
**Antidote** **Generation** **Module** to perform molecular docking and
the **Simulation** **Module** to create a dynamic 3D visualization.1

||
||
||
||

||
||
||
||
||

**Pillar** **3:** **Clinical** **&** **Pharmaceutical** **Data**
**(Outcomes,** **Eficacy,** **and** **Compounds)**

This is the "ground truth" data, providing the crucial correlation
between a virus's genetic makeup and its real-world health impact, which
is essential for the "Deadliness" score and validating antidote
eficacy.1 This data is the most fragmented, requiring a dedicated

**ETL** **(Extract,** **Transform,** **Load)** **pipeline** to clean and
normalize.1

||
||
||
||
||
||

||
||
||
||
